Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial
作者： J. Souglakos , A. Pallis , S. Kakolyris , D. Mavroudis , N. Androulakis
DOI: 10.1159/000089992
关键词: Bolus (medicine) 、 Irinotecan 、 Oncology 、 Colorectal cancer 、 Internal medicine 、 Fluorouracil 、 Antimetabolite 、 FOLFIRI Regimen 、 FOLFIRI 、 Surgery 、 Thymidylate synthase 、 Medicine
摘要: Purpose: To evaluate the efficacy and tolerance of irinotecan (CPT-11) in combination with bolus continuous infusion 5-fluorouracil (5-FU) leucovorin (LV) (FOLFIRI regime
sci-hub.se 参考文章(32)
Vincent Mor, Susan Masterson-Allen, Richard J. Goldberg, Francis J. Cummings, Arvin S. Glicksman, Marsha D. Fretwell, Relationship between age at diagnosis and treatments received by cancer patients. Journal of the American Geriatrics Society. ,vol. 33, pp. 585- 589 ,(1985) , 10.1111/J.1532-5415.1985.TB06313.X
Michelle G. Lihou, Yaw-Huei Hsiang, Leroy F. Liu, Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin Cancer Research. ,vol. 49, pp. 5077- 5082 ,(1989)
M A Poon, M J O'Connell, C G Moertel, H S Wieand, S A Cullinan, L K Everson, J E Krook, J A Mailliard, J A Laurie, L K Tschetter, Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. Journal of Clinical Oncology. ,vol. 7, pp. 1407- 1418 ,(1989) , 10.1200/JCO.1989.7.10.1407
C H Köhne, P Schöffski, H Wilke, C Käufer, R Andreesen, U Ohl, U Klaasen, M Westerhausen, W Hiddemann, G Schott, A Harstick, J Bade, A Horster, U Schubert, H Hecker, B Dörken, H J Schmoll, Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. Journal of Clinical Oncology. ,vol. 16, pp. 418- 426 ,(1998) , 10.1200/JCO.1998.16.2.418
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Lodovico Balducci, Martine Extermann, Cancer chemotherapy in the older patient : What the medical oncologist needs to know Cancer. ,vol. 80, pp. 1317- 1322 ,(1997) , 10.1002/(SICI)1097-0142(19971001)80:7<1317::AID-CNCR18>3.0.CO;2-A
Brian N. Stein, Nicholas J. Petrelli, Harold O. Douglass, Deborah L. Driscoll, Giuseppina Arcangeli, Neal J. Meropol, Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial Cancer. ,vol. 75, pp. 11- 17 ,(1995) , 10.1002/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N
Daniel J. Sargent, Richard M. Goldberg, Stacy D. Jacobson, John S. Macdonald, Roberto Labianca, Daniel G. Haller, Lois E. Shepherd, Jean François Seitz, Guido Francini, A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. The New England Journal of Medicine. ,vol. 345, pp. 1091- 1097 ,(2001) , 10.1056/NEJMOA010957
Joyce Steinberg, Charles Erlichman, Tahany Gadalla, Sheldon Fine, Alfred Wong, Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. European Journal of Cancer. ,vol. 28, pp. 1817- 1820 ,(1992) , 10.1016/0959-8049(92)90011-P